局所止血剤の世界市場：市場規模・シェア・動向分析 (種類別・用途別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

局所止血剤の市場規模と動向：

局所止血剤の世界市場規模は2024年に59億米ドルとなり、2025年から2030年にかけてCAGR 9.4％で成長すると予測されています。

この業界は、外科手術の増加、外傷症例の増加、止血技術の進歩により成長しています。これらの製品は、心臓血管、整形外科、神経外科などの手術における出血をコントロールするために広く使用されています。需要は、創傷治癒の迅速化、外科的合併症の減少、患者の転帰改善に対するニーズが後押ししています。特に新興市場における医療インフラの成長と低侵襲手術の増加は、市場成長をさらに促進します。

最近の事例では、ガーゼのような従来の止血材の限界が浮き彫りになりました。手術後の患者に意図せず止血材が存在することで、痛み、炎症、感染が引き起こされたのです。ガーゼや医療用バンドのような従来の材料は、主に表面出血を抑制しますが、出血部位への密着性に欠け、汚染されやすいです。フィブリン糊やコラーゲンスポンジのような代替材料は、生分解性ですが、ヒトまたは動物由来のタンパク質に依存しているため高価です。

研究開発者らはこれらの限界に対処し、イガイやカイコの繭から採取した天然タンパク質を用いた革新的な二層ナノファイバー膜止血材を開発しました。この新しい止血材は、強力な組織接着力、効果的な出血コントロール、感染防御を提供します。チャ・ヒョンジュン教授を中心とするPOSTECH、梨花女子大学、ソウル聖母病院の共同研究チームは、この研究を2024年2月に学術誌Smallに発表しました。この止血剤は、迅速な止血のために血小板を活性化させるイガイ接着タンパク質と、メタノール蒸気で改質された疎水性ナノファイバー外層を形成するカイコの絹フィブロインを統合したものです。この二層構造により、生体適合性、生分解性、強固な感染予防が保証されます。

動物実験では、この薬剤が出血創の組織接着と止血を促進する能力があることが実証されました。内層は接着を促進し、外層は水系汚染物質やバクテリアから保護します。これらの進歩は、既存の止血材の重大な欠点に対処するものであり、外科用途により安全で多機能な解決策を提供するものです。研究チームは、この止血材が実際の外科手術に使用される可能性があり、患者ケアに大きな影響を与えることを強調しています。

産業界は、このような技術革新に対する認識の高まりと、資金援助や研究支援から利益を得ています。韓国の海洋バイオ材料研究センター・プログラムと国家研究財団の支援を受けたこの調査は、市場成長促進における政府のイニシアチブの重要性を浮き彫りにしています。先進的で費用対効果が高く、生体適合性の高い止血剤に対する需要が高まる中、技術的なブレークスルーと、より安全な手術結果の継続的な追求に後押しされ、同市場は大幅に拡大する見通しです。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 局所止血剤市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• 局所止血剤市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 局所止血剤市場：種類別の推定・動向分析

• セグメントダッシュボード
• 局所止血剤市場：変動分析、種類別
• 局所止血剤市場の展望：種類別
• 市場規模の予測と動向分析 (2018～2030年)
• フィブリン
• トロンビン
• セルロース
• コラーゲン
• ゼラチン
• 接着剤
• その他

第5章 局所止血剤市場：用途別の推定・動向分析

• セグメントダッシュボード
• 局所止血剤市場：変動分析、用途別
• 局所止血剤市場の展望：用途別
• 市場規模の予測と動向分析 (2018～2030年)
• 一般外科
• 脳神経外科
• 血管外科
• 心臓血管外科
• その他

第6章 局所止血剤市場：最終用途別の推定・動向分析

• セグメントダッシュボード
• 局所止血剤市場：変動分析、最終用途別
• 局所止血剤市場の展望：最終用途別
• 市場規模の予測と動向分析 (2018～2030年)
• 病院
• 外来手術センター
• その他

第7章 局所止血剤市場：地域別の推定・動向分析

• 地域ダッシュボード
• 局所止血剤市場：変動分析、技術別
• 局所止血剤市場の展望：技術別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • BD
  • Medicom
  • Baxter
  • HemoSonics
  • Hemostasis, LLC
  • Medline Industries
  • Pfizer Inc.
  • Johnson &Johnson
  • HemCon Medical Technologies Inc.
  • Integra LifeSciences
  • Teleflex Incorporated

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 4. Global topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 5. Global topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 6. North America topical hemostat market, by region, 2018 - 2030 (USD Million)
• Table 7. North America topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 8. North America topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 9. North America topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 10. U.S. topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 11. U.S. topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 12. U.S. topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 13. Canada topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 14. Canada topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 15. Canada topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 16. Mexico topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 17. Mexico topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 18. Mexico topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 19. Europe topical hemostat market, by country, 2018 - 2030 (USD Million)
• Table 20. Europe topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 21. Europe topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 22. Europe topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 23. UK topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 24. UK topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 25. UK topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 26. Germany topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 27. Germany topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 28. Germany topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 29. France topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 30. France topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 31. France topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 32. Italy topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 33. Italy topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 34. Italy topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 35. Spain topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 36. Spain topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 37. Spain topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 38. Norway topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 39. Norway topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 40. Norway topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 41. Sweden topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 42. Sweden topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 43. Sweden topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 44. Denmark topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 45. Denmark topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 46. Denmark topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific topical hemostat market, by country, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 51. Japan topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 52. Japan topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 53. Japan topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 54. China topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 55. China topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 56. China topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 57. India topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 58. India topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 59. India topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 60. Australia topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 61. Australia topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 62. Australia topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 63. South Korea topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 64. South Korea topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 65. South Korea topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 66. Thailand topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 67. Thailand topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 68. Thailand topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 69. Latin America topical hemostat market, by country, 2018 - 2030 (USD Million)
• Table 70. Latin America topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 71. Latin America topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 72. Latin America topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 73. Brazil topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 74. Brazil topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 75. Brazil topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 76. Argentina topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 77. Argentina topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 78. Argentina topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 79. Middle East & Africa topical hemostat market, by country, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 83. South Africa topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 84. South Africa topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 85. South Africa topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 86. Saudi Arabia topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 89. UAE topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 90. UAE topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 91. UAE topical hemostat market, by end-use, 2018 - 2030 (USD Million)
• Table 92. Kuwait topical hemostat market, by type, 2018 - 2030 (USD Million)
• Table 93. Kuwait topical hemostat market, by application, 2018 - 2030 (USD Million)
• Table 94. Kuwait topical hemostat market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Topical hemostat market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Topical hemostat market, type outlook key takeaways (USD Million)
• Fig. 12 Topical hemostat market type movement analysis 2023 & 2030 (USD Million)
• Fig. 13 Fibrin market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Thrombin market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Cellulose market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Collagen market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Gelatin market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Adhesives market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Topical hemostat market, application outlook key takeaways (USD Million)
• Fig. 21 Topical hemostat market application movement analysis 2023 & 2030 (USD Million)
• Fig. 22 General surgery market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Neurosurgery market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Vascular surgery market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Cardiovascular surgery market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Topical hemostat market, end-use outlook key takeaways (USD Million)
• Fig. 28 Topical hemostat market end-use movement analysis 2023 & 2030 (USD Million)
• Fig. 29 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Topical hemostat market: Regional key takeaways (USD Million)
• Fig. 33 Topical hemostat market regional outlook, 2023 & 2030 (USD Million)
• Fig. 34 North America topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 US topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Canada topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Mexico topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Europe topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 UK topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Germany topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 France topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Spain topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Italy topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Sweden topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Norway topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Denmark topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Asia Pacific topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 China topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Japan topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 India topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 South Korea topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Australia topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Thailand topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Latin America topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Brazil topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Argentina topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Middle East and Africa topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 South Africa topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Saudi Arabia topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 UAE topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Kuwait topical hemostat market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 List of key emerging company's/technology disruptors/innovators

Topical Hemostat Market Size & Trends:

The global topical hemostat market size was valued at USD 5.9 billion in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The industry is growing due to rising surgical procedures, increasing trauma cases, and advancements in hemostatic technologies. These products are widely used to control bleeding in surgeries, including cardiovascular, orthopedic, and neurosurgical procedures. The demand is fueled by the need for faster wound healing, reduced surgical complications, and improved patient outcomes. Growing healthcare infrastructure, particularly in emerging markets, and the rise in minimally invasive procedures further drive market growth.

A recent case underscored the limitations of conventional hemostatic materials like gauze, where its unintended presence in a patient post-surgery caused pain, inflammation, and infection. Traditional materials such as gauze and medical bands primarily control surface bleeding but lack adherence to bleeding sites and are prone to contamination. Alternatives like fibrin glue and collagen sponges, though biodegradable, are expensive due to reliance on human or animal-derived proteins.

Researchers have addressed these limitations and developed an innovative bilayer nanofiber membrane hemostat using natural proteins from mussels and silkworm cocoons. This novel hemostat offers strong tissue adhesion, effective bleeding control, and protection against infection. Led by Professor Hyung Joon Cha and a collaborative team from POSTECH, Ewha Womans University, and Seoul St. Mary's Hospital, the research was published in the journal Small in February 2024. The hemostatic agent integrates mussel adhesive proteins, which activate platelets for rapid hemostasis, and silk fibroin from silkworms, modified with methanol vapor to create a hydrophobic nanofiber outer layer. This dual-layer design ensures biocompatibility, biodegradability, and robust infection prevention.

Animal experiments demonstrated the agent's ability to accelerate tissue adhesion and hemostasis in bleeding wounds. Its inner layer enhances adhesion while the outer layer protects against waterborne contaminants and bacteria. These advancements address critical shortcomings in existing hemostatic materials, offering a safer, multifunctional solution for surgical applications. The research team emphasized the agent's potential for real-world surgical settings and its transformative impact on patient care.

The industry benefits from growing awareness of such innovations, as well as funding and research support. This study, supported by Korea's Marine Bio Materials Research Center Program and the National Research Foundation, highlights the importance of government initiatives in driving market growth. As demand for advanced, cost-effective, and biocompatible hemostatic agents rises, the market is poised for substantial expansion, propelled by technological breakthroughs and the continuous pursuit of safer surgical outcomes.

Global Topical Hemostat Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global topical hemostat market report on the basis of type, application, end-use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Fibrin
• Thrombin
• Cellulose
• Collagen
• Gelatin
• Adhesives
• Others
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgical Centers
• Others
• Region Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Topical Hemostat Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Topical Hemostat Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Topical Hemostat Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Topical Hemostat Market: Type Movement Analysis
• 4.3. Topical Hemostat Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Fibrin
  • 4.5.1. Fibrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Thrombin
  • 4.6.1. Thrombin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Cellulose
  • 4.7.1. Cellulose Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Collagen
  • 4.8.1. Collagen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Gelatin
  • 4.9.1. Gelatin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.10. Adhesives
  • 4.10.1. Adhesives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Topical Hemostat Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Topical Hemostat Market: Application Movement Analysis
• 5.3. Topical Hemostat Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. General Surgery
  • 5.5.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Neurosurgery
  • 5.6.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Vascular Surgery
  • 5.7.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Cardiovascular Surgery
  • 5.8.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Topical Hemostat Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Topical Hemostat Market: End-use Movement Analysis
• 6.3. Topical Hemostat Market by Ens-use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Topical Hemostat Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Topical Hemostat Market movement analysis
• 7.3. Topical Hemostat Market: Regional Estimates & Trend Analysis by Technology & Usability
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Topical Hemostat Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. BD
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Type benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Medicom
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Type benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Baxter
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Type benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. HemoSonics
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Type benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Hemostasis, LLC
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Type benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Medline Industries
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Type benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Pfizer Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Type benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Johnson & Johnson
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Type benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. HemCon Medical Technologies Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Type benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Integra LifeSciences
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Type benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Teleflex Incorporated
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Type benchmarking
    • 8.2.11.4. Strategic initiatives